Skip to content

Author

Y. Agarwala

We have 2 of 11 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

IUC26692-90 Benchmarking Artificial Intelligence-Based Clinical Prediction Models for Immune Checkpoint Inhibitor Response and Overall Survival in Bladder Cancer

Abstract Background Bladder cancer (BLCA) is a common urological malignancy with high recurrence and heterogeneous treatment response. Immune checkpoint inhibitors (ICIs) have transformed advanced BLCA treatment, yet response prediction remains challenging. AI-based models have been developed to predict ICI response an...

R. Das, B. Gonsalves, V. Ravindran et al. · 0 citations
Open access Jul 2026

New Therapeutic Cancer Vaccine with Lenalidomide Induces Potent T Cell Immunity and Inhibits HPV E6/E7-Expressing Tumor Growth in Mice.

Current prophylactic human papillomavirus (HPV) vaccines prevent infection but have limited therapeutic benefit in established HPV-driven malignancies. To address this unmet need, we developed VTX-067, a modular self-assembling therapeutic cancer vaccine consisting of a recombinant Mycobacterium tuberculosis heat shock...

Y. Gemechu, Sonia Mukherjee, J. Gelfand et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.